[235 Pages Report] Worldwide demand for orthotic devices, casts, and splints is expected to increase at a CAGR of 6.2% over the forecast period (2022 to 2024). The global orthotic devices, casts, and splints market is valued at US$ 2.95 Billion in 2022, and is projected to reach US$ 3.32 Billion by the end of 2024.
| Attribute | Details |
|---|---|
| Orthotic Devices, Casts, and Splints Market Size (2022) | US$ 2.95 billion |
| Sales Forecast (2024) | US$ 3.32 billion |
| Global Market Growth Rate (2022 to 2024) | 6.2% CAGR |
| North America Region USD Share | 38% |
Sales of orthotic devices, casts, and splints accounted for 28% share of the global fracture fixation products market in 2021.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
| Particulars | Details |
|---|---|
| H1, 2021 | 5.39% |
| H1, 2022 Projected | 5.54% |
| H1, 2022 Outlook | 5.24% |
| BPS Change - H1, 2022 (O) - H1, 2022 (P) | (-) 30 ↓ |
| BPS Change - H1, 2022 (O) - H1, 2021 | (-) 15 ↓ |
According to Future Market Insights' analysis, the global orthotic devices, casts and splints market expects to drop by 15 Basis Point Share (BPS) in H1-2022 as compared to H1- 2021. Whereas in comparison to H1-2022 projected value, the market during H1-2022 outlook period will show a dip of 30 BPS.
The drop in the BPS values is associated with the costs related to the replacement, repairs, and modifications of orthotic devices. Moreover, significant drawbacks concerning the interaction of orthotic devices, such as, orthosis and prosthetics, with respect to material properties, has further provided a restraint towards the growth in the BPS outlook.
Conversely, with the introduction of 3D printing technology and the adoption of CAD/CAM, the manufacturing costs of orthotic devices, casts and splints will significantly be reduced. This factor is set to propel the growth of the market through the forecasted years.
Key developments in the market include incorporation of neuromuscular signal technology, microprocessor technology, and 3D printing for novel orthotic devices.
“Rising Incidence of Sports Injuries Worldwide Driving Market Growth”
From 2014 to 2021, the market value of the orthotic devices, casts, and splints industry registered a CAGR of 5.8%.
Orthotic devices, casts, and splints are a key management option for various types of injuries. The increase in the number of injuries suffered due to road accidents, as well as during recreational and professional sporting events has remained a key market driver.
As per ASIRT (Association of System Integrators and Retailers in Technology), almost 50 million people get adversely affected by road accidents every single year globally.
Also, per the AAOS (American Academy of Orthopedic Surgeons), over 25% of sports injuries concern lower extremities. The CDC states that close to 9.2 Mn children aged 1 to 19 get admitted to the emergency departments in the wake of sports injuries. Moreover, around 62% of sports injuries occur during practice than during actual games.
Increasing prevalence of age-related osteoporotic fractures, musculoskeletal problems, and trauma caused by road accidents and falls, as well as the growing geriatric population, are likely to drive the global market.
The global orthotic devices, casts, and splints market is projected to rise at a 6.2% CAGR from 2022 to 2024.
“Advancements in 3D Technology to Boost Sales of Orthotic Devices, Casts, and Splints”
The orthotic devices, casts, and splints industry will be revolutionized by rising technologies such as 3D imaging and scanning, CAM/CAD, and so on. These technologies will become more widely available in the future years, allowing patients to 3D print orthotic devices in the comfort of their own homes.
As people seek alternatives to surgical deformity repair and pain management, the use of orthotic devices will be promoted around the world. Furthermore, advancements in orthotic devices are making them more accessible and affordable.
Factors such as continuous technological advancements in 3D technology, increase in the number of people suffering from orthopedic ailments, and requirement for robot-assisted and minimally invasive techniques are offering substantial growth opportunities for orthotic system manufacturers.
Principal Consultant
“High Cost of Orthotic Devices & Complications with Orthopedic Surgery Hampering Market Expansion”
One of the most significant challenges impeding the market growth is the high cost of orthotic devices.
Inadequately trained medical attendants and nurses apply casts in rural areas. This could result in complications as discomfort on the part of patients could be higher. This factor remains a challenge, especially in developing economies as overcrowding of patients in city-based hospitals makes treatments difficult.
“Continuous Innovations in Orthotics Driving Market Growth in North America”
North America is expected to account 38% share of the orthotic devices, casts, and splints market in 2022. The use of orthotic devices for pain management in the senior population, the increase in sports injuries, the rise in the incidence of spine diseases, and the rise in the incidence of neuromuscular and musculoskeletal illnesses among the population are all driving the market expansion.
Innovations in orthotics and well-planned reimbursement regulations are expected to drive orthotic devices market growth over the coming years.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
“High Adoption of Advanced Products Fueling U.S. Market Growth”
Rising adoption of universal health coverage in developed and developing markets, rising product launches, steadily increasing healthcare infrastructure and expenditure, and the presence of key suppliers of orthotic devices, casts, and splints are key factors propelling orthotic systems market growth in the United States.
Skilled professionals, availability of refined and advanced items, and rising demand for advanced products and therapies are driving orthotic equipment market growth in the U.S.
“Favorable Government Initiatives for Improvement of Healthcare Facilities Driving Demand Growth”
Market growth in China is anticipated to expand at a rapid pace during the forecast period due to the rising rate of urbanization and government attempts to improve healthcare facilities.
Furthermore, propelling medical tourism due to the availability of cost-effective and advanced healthcare treatment alternatives, a rise in disposable income, and increased adoption of novel technology are bolstering the market growth in China.
“Splinting Supplies & Equipment Gaining Traction Owing to Their Cost-effective Nature”
Splinting supplies & equipment are predicted to develop rapidly over the coming years due to advantages such as the simplicity of making plastic splints, which allows for quick customization, and the high adaptability and strength of neoprene splints.
Increased instances of road accidents and musculoskeletal injuries, a growing population base of people over the age of 65, and the frequency of orthopedic complications associated with ageing are driving the demand for orthopedic casts and splints.
The capacity of these products to enhance patient compliance in terms of secured support and comfort over the course of treatment, rising technological advancements, and the use of advanced materials by manufacturers are driving demand for splinting supplies and equipment.
“Hospitals to Generate Highest Market Revenue Due to Growing Number of Orthopedic Surgery Operations”
Hospitals have a considerable market share due to an increase in the number of admissions for the treatment of traumatic and spinal injuries, bone fractures, and injuries incurred in car accidents.
Demand for orthotic devices, casts, and splints in hospitals is being driven by an increase in the number of orthopedic surgical operations that require post-operative patient rehabilitation and favorable reimbursement for personalized orthotic devices across major countries.
Hospitals utilize orthotic devices, casts, and splints for a variety of reasons, including preventive, post-operative patient rehabilitation, osteoarthritis treatment, and maxillofacial operations. Orthotic devices, casts, and splints are the most commonly used in hospitals because of their extensive use in the treatment of spinal fusion and delayed union and nonunion bone fractures.
The COVID-19 pandemic hampered the global economy and brought the closure of thousands of businesses worldwide. Demand for orthotic devices, casts and splints witnessed a drop because of a decline in hospital visits and a decrease in the number of road mishaps and sports activities.
On the other hand, the growing focus on decision-making processes for the treatment of acute pediatric injuries and the large emphasis on the risk/benefit ratio for proceeding with acute fracture surgeries are expected to drive market growth over the coming years.
Shortfalls in conventional manufacturing processes of orthotics imply that it could take ages for patients to acquire the devices that they require. As such, technological advancements are being focused upon. These advancements are likely to create a competitive edge for providers of orthotic devices, casts, and splints during the forecast period.
Companies are continuously coming up with new ways to ramp up production, such as capacity increases and new product development. To boost revenue sales, they are also focusing on partnership-oriented techniques such as acquisitions and mergers.
For instance,
| Attribute | Details |
|---|---|
| Forecast Period | 2022-2024 |
| Historical Data Available for | 2014-2021 |
| Market Analysis | Value in US$ Mn, Volume in Units |
| Key Regions Covered |
|
| Key Countries Covered |
|
| Key Market Segments Covered |
|
| Key Companies Profiled |
|
Orthotic Devices, Casts, and Splints Market by Product Type:
Orthotic Devices, Casts, and Splints Market by Distribution Channel:
Orthotic Devices, Casts, and Splints Market by Region:
The global orthotic devices, casts, and splints market is expected to reach US$ 3.32 Bn by 2024.
North America accounts for 38% share of the global orthotic devices, casts, and splints market.
Fillauer LLC, ComfortFit Orthotic Labs Inc., Hanger Inc., Amfit Inc., and Ascent Meditech Ltd. are prominent manufacturers of orthotic devices, casts, and splints.
The global market for orthotic devices, casts, and splints is estimated to exhibit a CAGR of 6.2% during the forecast period (2022-2024).
Increasing count of bone diseases along with growing instances of trauma and road accidents are key factors driving orthotic systems market growth.
1. Executive Summary
1.1. Global Market Outlook
1.2. Key Trends & Market Dynamics
1.3. Industry Evolution
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Key Market Trends
4. Key Success Factors
4.1. Product Adoption / Usage Analysis
4.2. Key Regulations
4.3. Orthotic Devices for Injury Prevention
5. COVID19 Crisis Analysis
5.1. Current COVID19 Statistics
5.2. Current GDP Projection and Probable Impact
6. Global Orthotic Devices, Casts and Splints Market Demand Analysis 2014–2021 and Forecast, 2022-2024
6.1. Historical Market Volume (Units) Analysis, 2014–2021
6.2. Current and Future Market Volume (Units) Projections, 2022-2024
6.3. Y-o-Y Growth Trend Analysis
7. Global Orthotic Devices, Casts and Splints Market - Pricing Analysis
8. Global Orthotic Devices, Casts and Splints Market Demand (in Value or Size in US$ Mn) Analysis 2014–2021 and Forecast, 2022-2024
8.1. Historical Market Value (US$ Mn) Analysis, 2014–2021
8.2. Current and Future Market Value (US$ Mn) Projections, 2022-2024
8.2.1. Y-o-Y Growth Trend Analysis
8.2.2. Absolute $ Opportunity Analysis
9. Market Background
9.1. Macro-Economic Factors
9.1.1. Global aging population
9.1.2. Prevalence of orthopedic related disorders
9.2. Forecast Factors - Relevance & Impact
9.2.1. R&D Activities and Commercialization of New Products
9.2.2. Increased Application in Injury Prevention and Rehabilitation
9.2.3. Regulatory Imposition on Orthotic Devices, Casts and Splints Products
9.2.4. Advancements in Orthotic Devices
9.2.5. Growing Adoption Rate for Orthotic Devices, Casts and Splints
9.3. Market Dynamics
9.3.1. Drivers
9.3.2. Restraints
9.3.3. Opportunity Analysis
10. Global Orthotic Devices, Casts and Splints Market Analysis 2014–2021 and Forecast 2022-2024, by Product Type
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Product Type, 2014–2021
10.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Product Type, 2022 - 2024
10.3.1. Casting Supplies & Equipment
10.3.1.1. Plaster Casts
10.3.1.2. Casting Tapes
10.3.1.3. Cast Cutters
10.3.1.4. Casting Tools and Accessories
10.3.2. Splinting Supplies & Equipment
10.3.2.1. Fiberglass Splints
10.3.2.2. Plaster Splints
10.3.2.3. Other Splints
10.3.2.4. Splinting Tools and Accessories
10.3.3. Orthotics
10.3.3.1.1. Functional Orthotics
10.3.3.1.2. Accommodative Orthotics
10.4. Market Attractiveness Analysis By Product Type
11. Global Orthotic Devices, Casts and Splints Market Analysis 2014–2021 and Forecast 2022-2024, by Distribution channel
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Mn) Analysis By Distribution channel, 2014–2021
11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Distribution channel, 2022 - 2024
11.3.1. Institutional Sales
11.3.1.1. Hospitals
11.3.1.2. Orthopedic Clinics
11.3.1.3. Nursing Facilities
11.3.2. Retail Sales
11.3.2.1. Online Sales
11.3.2.2. Retail Pharmacies
11.3.2.3. Drug Stores
11.4. Market Attractiveness Analysis By Distribution channel
12. Global Orthotic Devices, Casts and Splints Market Analysis 2014–2021 and Forecast 2022-2024, by Region
12.1. Introduction / Key Findings
12.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Distribution channel, 2014–2021
12.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Distribution channel, 2022 - 2024
12.3.1. North America
12.3.2. Latin America
12.3.3. Europe
12.3.4. Middle East and Africa (MEA)
12.3.5. East Asia
12.3.6. South Asia
12.3.7. Oceania
12.4. Market Attractiveness Analysis By Region
13. North America Orthotic Devices, Casts and Splints Market Analysis 2014–2021 and Forecast 2022-2024
13.1. Pricing Analysis
13.2. Historical Market Size (US$ Mn) and Volume Analysis By Distribution channel, 2014–2021
13.3. Current and Future Market Size (US$ Mn) and Volume Analysis and Forecast By Distribution channel, 2022 - 2024
13.3.1. By Country
13.3.1.1. U.S.
13.3.1.2. Canada
13.3.2. By Product Type
13.3.3. By Distribution channel
13.4. Market Attractiveness Analysis
13.4.1. By Country
13.4.2. By Product Type
13.4.3. By Distribution channel
13.5. Drivers and Restraints - Impact Analysis
14. Latin America Orthotic Devices, Casts and Splints Market Analysis 2014–2021 and Forecast 2022-2024
14.1. Pricing Analysis
14.2. Historical Market Size (US$ Mn) and Volume Analysis By Distribution channel, 2014–2021
14.3. Current and Future Market Size (US$ Mn) and Volume Analysis and Forecast By Distribution channel, 2022 - 2024
14.3.1. By Country
14.3.1.1. Brazil
14.3.1.2. Mexico
14.3.1.3. Rest of Latin America
14.3.2. By Product Type
14.3.3. By Distribution channel
14.4. Market Attractiveness Analysis
14.4.1. By Country
14.4.2. By Product Type
14.4.3. By Distribution channel
14.5. Drivers and Restraints - Impact Analysis
15. Europe Orthotic Devices, Casts and Splints Market Analysis 2014–2021 and Forecast 2022-2024
15.1. Pricing Analysis
15.2. Historical Market Size (US$ Mn) and Volume Analysis By Distribution channel, 2014–2021
15.3. Current and Future Market Size (US$ Mn) and Volume Analysis and Forecast By Distribution channel, 2022 - 2024
15.3.1. By Country
15.3.1.1. Germany
15.3.1.2. Italy
15.3.1.3. France
15.3.1.4. U.K.
15.3.1.5. Spain
15.3.1.6. BENELUX
15.3.1.7. Russia
15.3.1.8. Rest of Europe
15.3.2. By Product Type
15.3.3. By Distribution channel
15.4. Market Attractiveness Analysis
15.4.1. By Country
15.4.2. By Product Type
15.4.3. By Distribution channel
15.5. Drivers and Restraints - Impact Analysis
16. South Asia Orthotic Devices, Casts and Splints Market Analysis 2014–2021 and Forecast 2022-2024
16.1. Pricing Analysis
16.2. Historical Market Size (US$ Mn) and Volume Analysis By Distribution channel, 2014–2021
16.3. Current and Future Market Size (US$ Mn) and Volume Analysis and Forecast By Distribution channel, 2022 - 2024
16.3.1. By Country
16.3.1.1. India
16.3.1.2. Thailand
16.3.1.3. Indonesia
16.3.1.4. Malaysia
16.3.1.5. Rest of South Asia
16.3.2. By Product Type
16.3.3. By Distribution channel
16.4. Market Attractiveness Analysis
16.4.1. By Country
16.4.2. By Product Type
16.4.3. By Distribution channel
16.5. Drivers and Restraints - Impact Analysis
17. East Asia Orthotic Devices, Casts and Splints Market Analysis 2014–2021 and Forecast 2022-2024
17.1. Pricing Analysis
17.2. Historical Market Size (US$ Mn) and Volume Analysis By Distribution channel, 2014–2021
17.3. Current and Future Market Size (US$ Mn) and Volume Analysis and Forecast By Distribution channel, 2022 - 2024
17.3.1. By Country
17.3.1.1. China
17.3.1.2. Japan
17.3.1.3. South Korea
17.3.2. By Product Type
17.3.3. By Distribution channel
17.4. Market Attractiveness Analysis
17.4.1. By Country
17.4.2. By Product Type
17.4.3. By Distribution channel
17.5. Drivers and Restraints - Impact Analysis
18. Oceania Orthotic Devices, Casts and Splints Market Analysis 2014–2021 and Forecast 2022-2024
18.1. Pricing Analysis
18.2. Historical Market Size (US$ Mn) and Volume Analysis By Distribution channel, 2014–2021
18.3. Current and Future Market Size (US$ Mn) and Volume Analysis and Forecast By Distribution channel, 2022 - 2024
18.3.1. By Country
18.3.1.1. Australia
18.3.1.2. New Zealand
18.3.2. By Product Type
18.3.3. By Distribution channel
18.4. Market Attractiveness Analysis
18.4.1. By Country
18.4.2. By Product Type
18.4.3. By Distribution channel
18.5. Drivers and Restraints - Impact Analysis
19. Middle East and Africa Orthotic Devices, Casts and Splints Market Analysis 2014–2021 and Forecast 2022-2024
19.1. Pricing Analysis
19.2. Historical Market Size (US$ Mn) and Volume Analysis By Distribution channel, 2014–2021
19.3. Current and Future Market Size (US$ Mn) and Volume Analysis and Forecast By Distribution channel, 2022 - 2024
19.3.1. By Country
19.3.1.1. GCC Countries
19.3.1.2. Turkey
19.3.1.3. Northern Africa
19.3.1.4. South Africa
19.3.1.5. Rest of Middle East and Africa
19.3.2. By Product Type
19.3.3. By Distribution channel
19.4. Market Attractiveness Analysis
19.4.1. By Country
19.4.2. By Product Type
19.4.3. By Distribution channel
19.5. Drivers and Restraints - Impact Analysis
20. Key and Emerging Countries Respiratory Pathogen Testing Market Analysis 2014-2021 and Forecast 2022-2024
20.1. U.S. Respiratory Pathogen Testing Market Analysis
20.1.1. By Products
20.1.2. By Distribution Channel
20.2. Canada Respiratory Pathogen Testing Market Analysis
20.2.1. By Products
20.2.2. By Distribution Channel
20.3. Mexico Respiratory Pathogen Testing Market Analysis
20.3.1. By Products
20.3.2. By Distribution Channel
20.4. Brazil Respiratory Pathogen Testing Market Analysis
20.4.1. By Products
20.4.2. By Distribution Channel
20.5. U.K. Respiratory Pathogen Testing Market Analysis
20.5.1. By Products
20.5.2. By Distribution Channel
20.6. Germany Respiratory Pathogen Testing Market Analysis
20.6.1. By Products
20.6.2. By Distribution Channel
20.7. France Respiratory Pathogen Testing Market Analysis
20.7.1. By Products
20.7.2. By Distribution Channel
20.8. Italy Respiratory Pathogen Testing Market Analysis
20.8.1. By Products
20.8.2. By Distribution Channel
20.9. Spain Respiratory Pathogen Testing Market Analysis
20.9.1. By Products
20.9.2. By Distribution Channel
20.10. BENELUX Respiratory Pathogen Testing Market Analysis
20.10.1. By Products
20.10.2. By Distribution Channel
20.11. Russia Respiratory Pathogen Testing Market Analysis
20.11.1. By Products
20.11.2. By Distribution Channel
20.12. China Respiratory Pathogen Testing Market Analysis
20.12.1. By Products
20.12.2. By Distribution Channel
20.13. Japan Respiratory Pathogen Testing Market Analysis
20.13.1. By Products
20.13.2. By Distribution Channel
20.14. South Korea Respiratory Pathogen Testing Market Analysis
20.14.1. By Products
20.14.2. By Distribution Channel
20.15. India Respiratory Pathogen Testing Market Analysis
20.15.1. By Products
20.15.2. By Distribution Channel
20.16. ASEAN Respiratory Pathogen Testing Market Analysis
20.16.1. By Products
20.16.2. By Distribution Channel
20.17. Australia Respiratory Pathogen Testing Market Analysis
20.17.1. By Products
20.17.2. By Distribution Channel
20.18. New Zealand Respiratory Pathogen Testing Market Analysis
20.18.1. By Products
20.18.2. By Distribution Channel
20.19. GCC Countries Respiratory Pathogen Testing Market Analysis
20.19.1. By Products
20.19.2. By Distribution Channel
20.20. Turkey Respiratory Pathogen Testing Market Analysis
20.20.1. By Products
20.20.2. By Distribution Channel
20.21. Northern Africa Respiratory Pathogen Testing Market Analysis
20.21.1. By Products
20.21.2. By Distribution Channel
20.22. South Africa Respiratory Pathogen Testing Market Analysis
20.22.1. By Products
20.22.2. By Distribution Channel
21. Market Structure Analysis
21.1. Market Share Analysis of Top Players
21.1.1. Orthotic Devices, Casts and Splints Market Share Analysis
21.1.2. Casting Supplies & Equipment Market Share Analysis
21.1.3. Splinting Supplies & Equipment Market Share Analysis
21.1.4. Orthotics Market Share Analysis
22. Competition Analysis
22.1. Competition Dashboard
22.2. Competition Deep Dive
22.2.1. BSN Medical
22.2.1.1. Overview
22.2.1.2. Product Portfolio
22.2.1.3. Profitability by Market Segments (Product/Channel/Region)
22.2.1.4. Sales Footprint
22.2.1.5. Strategy Overview
22.2.1.5.1. Marketing Strategy
22.2.1.5.2. Product Strategy
22.2.1.5.3. Channel Strategy
22.2.2. De royal Industries, Inc.
22.2.2.1. Overview
22.2.2.2. Product Portfolio
22.2.2.3. Profitability by Market Segments (Product/Channel/Region)
22.2.2.4. Sales Footprint
22.2.2.5. Strategy Overview
22.2.2.5.1. Marketing Strategy
22.2.2.5.2. Product Strategy
22.2.2.5.3. Channel Strategy
22.2.3. Prime Medical
22.2.3.1. Overview
22.2.3.2. Product Portfolio
22.2.3.3. Profitability by Market Segments (Product/Channel/Region)
22.2.3.4. Sales Footprint
22.2.3.5. Strategy Overview
22.2.3.5.1. Marketing Strategy
22.2.3.5.2. Product Strategy
22.2.3.5.3. Channel Strategy
22.2.4. Performance Health Inc.
22.2.4.1. Overview
22.2.4.2. Product Portfolio
22.2.4.3. Profitability by Market Segments (Product/Channel/Region)
22.2.4.4. Sales Footprint
22.2.4.5. Strategy Overview
22.2.4.5.1. Marketing Strategy
22.2.4.5.2. Product Strategy
22.2.4.5.3. Channel Strategy
22.2.5. Össur Hf
22.2.5.1. Overview
22.2.5.2. Product Portfolio
22.2.5.3. Profitability by Market Segments (Product/Channel/Region)
22.2.5.4. Sales Footprint
22.2.5.5. Strategy Overview
22.2.5.5.1. Marketing Strategy
22.2.5.5.2. Product Strategy
22.2.5.5.3. Channel Strategy
22.2.6. DJO, LLC
22.2.6.1. Overview
22.2.6.2. Product Portfolio
22.2.6.3. Profitability by Market Segments (Product/Channel/Region)
22.2.6.4. Sales Footprint
22.2.6.5. Strategy Overview
22.2.6.5.1. Marketing Strategy
22.2.6.5.2. Product Strategy
22.2.6.5.3. Channel Strategy
22.2.7. Zimmer Biomet Holdings, Inc.
22.2.7.1. Overview
22.2.7.2. Product Portfolio
22.2.7.3. Profitability by Market Segments (Product/Channel/Region)
22.2.7.4. Sales Footprint
22.2.7.5. Strategy Overview
22.2.7.5.1. Marketing Strategy
22.2.7.5.2. Product Strategy
22.2.7.5.3. Channel Strategy
22.2.8. Stryker Corporation
22.2.8.1. Overview
22.2.8.2. Product Portfolio
22.2.8.3. Profitability by Market Segments (Product/Channel/Region)
22.2.8.4. Sales Footprint
22.2.8.5. Strategy Overview
22.2.8.5.1. Marketing Strategy
22.2.8.5.2. Product Strategy
22.2.8.5.3. Channel Strategy
22.2.9. 3M Healthcare
22.2.9.1. Overview
22.2.9.2. Product Portfolio
22.2.9.3. Profitability by Market Segments (Product/Channel/Region)
22.2.9.4. Sales Footprint
22.2.9.5. Strategy Overview
22.2.9.5.1. Marketing Strategy
22.2.9.5.2. Product Strategy
22.2.9.5.3. Channel Strategy
22.2.10. Ascent Meditech Ltd.
22.2.10.1. Overview
22.2.10.2. Product Portfolio
22.2.10.3. Profitability by Market Segments (Product/Channel/Region)
22.2.10.4. Sales Footprint
22.2.10.5. Strategy Overview
22.2.10.5.1. Marketing Strategy
22.2.10.5.2. Product Strategy
22.2.10.5.3. Channel Strategy
22.2.11. Fillauer LLC
22.2.11.1. Overview
22.2.11.2. Product Portfolio
22.2.11.3. Profitability by Market Segments (Product/Channel/Region)
22.2.11.4. Sales Footprint
22.2.11.5. Strategy Overview
22.2.11.5.1. Marketing Strategy
22.2.11.5.2. Product Strategy
22.2.11.5.3. Channel Strategy
22.2.12. ComfortFit Orthotic Labs, Inc.
22.2.12.1. Overview
22.2.12.2. Product Portfolio
22.2.12.3. Profitability by Market Segments (Product/Channel/Region)
22.2.12.4. Sales Footprint
22.2.12.5. Strategy Overview
22.2.12.5.1. Marketing Strategy
22.2.12.5.2. Product Strategy
22.2.12.5.3. Channel Strategy
22.2.13. Hanger, Inc.
22.2.13.1. Overview
22.2.13.2. Product Portfolio
22.2.13.3. Profitability by Market Segments (Product/Channel/Region)
22.2.13.4. Sales Footprint
22.2.13.5. Strategy Overview
22.2.13.5.1. Marketing Strategy
22.2.13.5.2. Product Strategy
22.2.13.5.3. Channel Strategy
22.2.14. Amfit Inc.
22.2.14.1. Overview
22.2.14.2. Product Portfolio
22.2.14.3. Profitability by Market Segments (Product/Channel/Region)
22.2.14.4. Sales Footprint
22.2.14.5. Strategy Overview
22.2.14.5.1. Marketing Strategy
22.2.14.5.2. Product Strategy
22.2.14.5.3. Channel Strategy
23. Assumptions and Acronyms Used
24. Research Methodology
Healthcare
December 2024
REP-GB-585
250 pages
Explore Healthcare Insights
View Reports
Orthotic Devices, Casts and Splints Market
